General Hospital Psychiatry
Volume 32, Issue 5 , Pages 556-558, September 2010

Successful treatment of comorbid obsessive–compulsive disorder with aripiprazole in three patients with bipolar disorder

Received 17 May 2010; accepted 13 July 2010. published online 01 September 2010.

Abstract 

Data on the efficacy of aripiprazole in obsessive–compulsive disorder (OCD), compared to data on the efficacy of other atypical antipsychotics, are inadequate. This report presents the successful treatment of concurrent OCD with aripiprazole in three patients with bipolar disorder (BD). Assessments performed with the Yale–Brown Obsessive–Compulsive Scale revealed significant reductions in OCD symptoms. Aripiprazole may be a beneficial psychotropic agent for the treatment of BD and OCD comorbidity, which is an important problem in clinical practice.

Keywords: Aripiprazole, Obsessive–compulsive disorder, Bipolar disorder

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0163-8343(10)00142-8

doi:10.1016/j.genhosppsych.2010.07.004

General Hospital Psychiatry
Volume 32, Issue 5 , Pages 556-558, September 2010